CI Investments Inc
CYTK icon

CI Investments Inc’s Cytokinetics CYTK Stock Holding History

CI Investments Inc’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-194
Closed -$11K – 804
2025
Q3 		$11K Sell
194
-1,567
-89% -$64.6K ﹤0.01% 1213
2025
Q2 		$58K Sell
1,761
-98
-5% -$3.41K ﹤0.01% 1005
2025
Q1 		$75K Sell
1,859
-1,129
-38% -$51.9K ﹤0.01% 983
2024
Q4 		$141K Buy
2,988
+332
+13% +$17.2K ﹤0.01% 839
2024
Q3 		$140K Buy
2,656
+34
+1% +$1.9K ﹤0.01% 756
2024
Q2 		$142K Sell
2,622
-3,317
-56% -$200K ﹤0.01% 721
2024
Q1 		$416K Buy
+5,939
New +$459K ﹤0.01% 507

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

CI Investments Inc's CYTK Position: Q4 2025 in Review

CI Investments Inc sold out of Cytokinetics (CYTK) in Q4 2025, closing a stake of 194 shares — an estimated $11K sold.

CI Investments Inc first reported a position in CYTK in Q1 2024 and held it in 7 quarters. The position peaked at $416K in Q1 2024. 430 funds tracked by Wall St. Rank hold CYTK as of Q4 2025.

  • CI Investments Inc reported no remaining Cytokinetics position as of Q4 2025 after selling out during the quarter.
  • CI Investments Inc sold 194 Cytokinetics shares in Q4 2025, an estimated $11K.
  • CI Investments Inc first reported a position in Cytokinetics in Q1 2024 and held it in 7 quarters.
  • CI Investments Inc's Cytokinetics position peaked at $416K in Q1 2024.
  • 430 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2025.

Based on CI Investments Inc's 13F filing for Q4 2025, filed 12 Feb 2026.